Syndax Pharmaceuticals Inc (SNDX) USD0.0001

Sell:$8.98Buy:$8.99No change

NASDAQ:1.02%
Market closed | Prices delayed by at least 15 minutes
Sell:$8.98
Buy:$8.99
Change:No change
Market closed | Prices delayed by at least 15 minutes
Sell:$8.98
Buy:$8.99
Change:No change
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
19 May 2025
Keith KatkinDirector
Buy
Regular purchase transaction
10,000$9.11$91,120.00100,000
19 May 2025
Keith A GoldanCFO
Buy
Regular purchase transaction
3,000$8.85$27,193.5093,746
19 May 2025
Martin H Jr HuberDirector
Buy
Regular purchase transaction
5,000$8.99$44,950.0079,000
16 May 2025
Nicholas A J (Nick) BotwoodOther Level A
Buy
Regular purchase transaction
11,765$9.00$105,826.1835,165
4 March 2025
Michael A MetzgerCEO
Sell
Option/Award related
7,814$15.05$117,563.97300,121
10 February 2025
Michael A MetzgerCEO
Sell
Tax related
13,288$15.50$206,017.15300,121
10 February 2025
Keith A GoldanCFO
Sell
Tax related
3,777$15.50$58,558.6190,746
10 February 2025
Neil GallagherOther President
Sell
Tax related
4,618$15.50$71,597.4785,095

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 February 2025
Michael A MetzgerCEO
Sell
Tax related
13,288$15.50$206,017.15300,121
4 March 2025
Michael A MetzgerCEO
Sell
Option/Award related
7,814$15.05$117,563.97300,121
16 May 2025
Nicholas A J (Nick) BotwoodOther Level A
Buy
Regular purchase transaction
11,765$9.00$105,826.1835,165
19 May 2025
Keith KatkinDirector
Buy
Regular purchase transaction
10,000$9.11$91,120.00100,000
10 February 2025
Neil GallagherOther President
Sell
Tax related
4,618$15.50$71,597.4785,095

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.